FDA Inspection 1132149 — Myrl D. Holida, PA-C
The FDA completed an inspection of Myrl D. Holida, PA-C on October 8, 2020 in Iowa City, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 8, 2020
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Iowa City, IA (United States)
Additional Details
Clinical Investigator (CI)